Ferozsons Laboratories Limited has been organizing the Liver Summit since 2011, bringing together leading local and international clinicians to share, learn, and discuss the latest scientific and evidence‑based advances in hepatology. The ultimate goal of this longstanding initiative is to improve outcomes for patients suffering from hepatitis and other liver diseases.

The theme of the 12th Liver Summit 2026, “Collaboration in Advancing Liver and Metabolic Health,” builds on the success of previous years and highlights the growing need for integrated, multidisciplinary care. This year’s focus emphasizes collaboration between hepatologists, diabetologists, and other allied healthcare professionals to develop a comprehensive perspective on the close interconnection between metabolic and liver health, while exploring innovative approaches to integrated liver care.

The summit will feature interactive sessions and panel discussions addressing pressing clinical challenges, complemented by didactic lectures on treatment breakthroughs, updates in hepatitis management, and emerging concerns in liver-related diseases. A dedicated Best of AASLD Debrief Session will also be included, presenting key highlights, practice-changing evidence, and expert perspectives from the latest American Association for the Study of Liver Diseases (AASLD) meeting, with insights tailored to local clinical practice.

Liver Summit 2026 aims to strengthen the link between clinical practice and patient outcomes. Through collaborative dialogue and shared expertise, the summit seeks to advance understanding of liver–metabolic health interconnections and to improve patient outcomes through joint efforts in prevention, management, and innovation.